Medical affairs outsourcing trends and benefits
What is the outlook for medical affairs up to 2030, and what are the advantages for pharma and biotechs from outsourcing this function to external specialists?
Medical Affairs
News Category
Challenges and Trends in Medical Affairs
Medical affairs is an increasingly complex discipline. It is vital that the team is highly trained and able to adapt to an evolving environment, liaising effectively with stakeholders to communicate value and bring new treatments to the market. Read on to discover some of the challenges and trends affecting the sector.
Breakfast Briefing Takeaways: Beyond the Numbers… Strategic Partnering with your Statistical Colleagues
For our latest virtual breakfast briefing, PharmaMedic Managing Director Dr Malcolm Barratt-Johnson discussed with guest speakers Dr Nelson Kinnersley and Dr Alexander Schacht – both seasoned statistical leaders- how partnering with your statistician can add value throughout the product life cycle. If you missed it, read on for a summary of key takeaways and to access a recording of the event.
Join Our Free Webinar: Beyond the Numbers… Strategic Partnering with your Statistical Colleagues
PharmaMedic is delighted to announce our next virtual event on Wednesday 29th June 2022 at 8 am (GMT). In this briefing, we will be discussing the integral role that statisticians, and innovative statistical approaches play in enabling medical, clinical, and commercial teams to make better development decisions, conduct more efficient research, and ensure more successful commercialisation. We are delighted to welcome as speakers two seasoned statistical leaders, Nelson Kinnersley, Founder and Director at Octa Consulting Services Ltd, and Alexander Schacht, Executive VP Launch and Commercialisation Data Science at Veramed. Read on to learn more, and to register your attendance.
Takeaways from our April joint webinar- Medical Affairs 3.0: A Discipline Comes of Age
We enjoyed our first joint webinar with PharmaMedic and Triducive of 2022. Our guest speakers, Dr Malcolm Barratt-Johnson (PharmaMedic) and Tim Warren (Triducive) joined Nick Williams (Triducive) for a discussion and interactive Q&A on the evolving and increasingly strategic role of medical affairs within pharma and life sciences businesses. Read on for the key takeaways.
Living with COVID- the role of antivirals
In the UK, we now seem to be moving into a new phase of pandemic management, with the government aiming to” transition to managing COVID-19 like other respiratory illnesses”. In their recent March 2022 statement, the government attributes this evolution in approach to vaccines and treatments. In this short article, we overview the current role of antivirals and monoclonal antibodies and look ahead to future developments in our attempt to manage the day-to day risks of living with COVID-19.
Join Our Free Webinar: Medical Affairs 3.0: A Discipline Comes of Age – Focus on evidence generation & dissemination for strategic impact
Join Triducive and PharmaMedic for an interactive webinar on Thursday 28th April at 8.00AM. Keynote speakers Dr Malcolm Barratt-Johnson and Tim Warren will be discussing the strategic role of medical affairs in Pharma and the potential role of Delphi based studies for strategic impact. Find out more.
The value of a pharmaceutical physician as a Non-Executive Director
Non-Executive Directors play an integral role for any organisation, not least within the life science space where leadership often needs to draw on a broad range of strategic and tactical expertise to drive the business forward. In this short Q&A article, we interview PharmaMedic Managing Director Dr Malcolm Barratt-Johnson about the value that a pharmaceutical physician delivers in the role of NED.
Join our Virtual Breakfast Briefing: Medical Affairs in 2022: Business as usual, or a reshaped environment?
PharmaMedic is delighted to announce our next virtual breakfast briefing on Thursday 24th February 2022 at 8 am. For this virtual session, we invite you to join experts Dr Malcolm Barratt-Johnson, Mr Guy Francis, Dr Lucy Cook and Mr Andrew Wise for a lively panel discussion tackling the key industry and medical affairs trends we expect to emerge in 2022 and how we can best adapt to succeed. Learn more about the agenda and register here.
The Role of Public/ Private Collaborations in Innovation- Highlights from our Virtual Breakfast Briefing
Against a backdrop of achievements yielded from public/private collaborations in the context of the pandemic response, we focused our latest virtual briefing on the crucial role such partnerships play in furthering biopharma and medical devices innovation. We share highlights from the event and provide the catch-up recording in this brief summary.